发生的帕金森病患者中的2型糖尿病风险:20年回顾性基于人口的队列研究
Neuroepidemiology
|January 26, 2026
概括
在男性帕金森病患者中,患2型糖尿病 (T2DM) 的风险较低. 在PD患者中,无并发性T2DM与较低的死亡风险有关,这表明性别特异性联系.
科学领域:
- 神经学 神经学
- 内分泌学 在内分泌学.
- 流行病学 流行病学
背景情况:
- 帕金森病 (PD) 和2型糖尿病 (T2DM) 分享了诸如炎症和胰岛素抵抗等机制.
- 虽然T2DM增加了PD风险,但新患PD患者的T2DM风险不太了解.
研究的目的:
- 为了确定发生病例的PD患者中发展T2DM的风险.
- 评估T2DM对PD患者死亡率的影响.
主要方法:
- 一项以人口为基础的回顾性队列研究,对7976名发生病例的PD患者 (2000-2019) 进行了研究.
- 根据年龄,性别和并发症调整的考克斯回归模型被用于评估T2DM发病和死亡风险.
主要成果:
- 8.4%的PD患者在平均7.1年的随访期间发展为T2DM.
- 男性性别与较低的T2DM发病风险相关 (HR=0.77).
- 没有并发症的T2DM的PD患者的死亡风险低于非糖尿病PD患者 (HR=0.70).
结论:
- 在没有糖尿病的男性PD患者中,T2DM的风险相对较低.
- 在PD患者中不复杂的T2DM与死亡率降低有关.
- 结果表明性别特异性机制,并强调在PD研究中考虑并发症时间.
更多相关视频
04:36Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
1.9K
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
1.2K
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
4.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
Type I Diabetes II: Pathophysiology
75
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
17
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
17
Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
